VTE Prophylaxis

General Recommendations

The table below provides a brief summary of the ACCP 2008 International Recommendations for the prevention of VTE.  If you would like to view complete recommendations, please visit http://www.chestjournal.org/

ACCP 2008
Heparin Induced Thrombocytopenia No platelet monitoring for UFH/LMWH : 2C
Treatment with fondaparinux: 2C
No platelet monitoring for fondaparinux: 1C
Prevention of VTE general aspects Mechanical if high bleeding risk: 1A
No use of aspirin: 1A
Need for renal function assessment: 1A
Please Log in
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to this content.

Already Registered?

Email    Password   

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students. 

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major theraputic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

If you are not a healthcare professional please visit our patient site.

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

Exit Log in